Further processing options
Efficacy, immunogenicity and safety of the AS04‐HPV‐16/18 vaccine in Chinese women aged 18‐25 years: End‐of‐study results from a phase II/III, randomised, controlled trial...
Saved in:
Journal Title: | Cancer Medicine |
---|---|
Authors and Corporations: | , , , , , , , , , , , , , , , , , , , , , , , , , , , |
In: | Cancer Medicine, 8, 2019, 14, p. 6195-6211 |
Type of Resource: | E-Article |
Language: | English |
published: |
Wiley
|
Subjects: |